| Filed On | Filing |
|---|---|
| 19 Mar 2026 |
Form 3: Sharma Mani, See Remarks
Holds 31,153.4659 shares of Ordinary Shares |
| 07 Feb 2020 |
Form 3: Astrazeneca Plc, 10% owner and 1 other · Aevi Genomic Medicine, LLC
Holds 12,946,900 shares of Common Stock |
| 02 Oct 2019 |
Form 3: Astrazeneca Plc, 10% owner · Viela Bio, Inc.
Holds 10 shares of Common Stock |
| 17 Oct 2018 | Form 3: Astrazeneca Plc, 10% owner and 1 other · PhaseBio Pharmaceuticals Inc |
| 25 Sep 2018 |
Form 3: Astrazeneca Plc, 10% owner and 1 other · Entasis Therapeutics Holdings Inc.
Holds 4 shares of Common Stock |
| 07 Nov 2016 |
Form 3: Astrazeneca Plc, 10% owner and 1 other · ALBIREO PHARMA, INC.
Holds 1,008,141 shares of Common Stock |
| 12 Oct 2012 |
Form 3: Astrazeneca Plc, 10% owner and 1 other · Regulus Therapeutics Inc.
Holds 6,250,000 shares of COMMON STOCK |
| 01 May 2012 |
Form 3: Astrazeneca Plc, 10% owner · Ardea Biosciences, Inc./DE
Holds 0 shares of Common Stock |
Loading...
